🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/08/2003 | 9,45 | 9,55 | 9,20 | 9,33 | -1,01% | 3,70% | 483.000 |
| 01/08/2003 | 9,73 | 9,84 | 9,43 | 9,43 | -4,07% | 4,21% | 310.800 |
| 31/07/2003 | 9,61 | 9,95 | 9,60 | 9,83 | +1,60% | 3,59% | 947.000 |
| 30/07/2003 | 9,93 | 9,93 | 9,60 | 9,67 | -2,22% | 3,32% | 164.600 |
| 29/07/2003 | 9,71 | 9,99 | 9,59 | 9,89 | +3,02% | 4,17% | 573.600 |
| 28/07/2003 | 9,60 | 10,28 | 9,52 | 9,60 | -0,52% | 7,86% | 1.020.200 |
| 25/07/2003 | 9,52 | 9,68 | 9,38 | 9,65 | +1,69% | 3,15% | 210.200 |
| 24/07/2003 | 9,53 | 9,56 | 9,35 | 9,49 | -0,32% | 2,20% | 293.000 |
| 23/07/2003 | 9,60 | 9,70 | 9,37 | 9,52 | -0,31% | 3,44% | 320.400 |
| 22/07/2003 | 9,38 | 9,59 | 9,38 | 9,55 | +1,33% | 2,19% | 1.177.600 |
| 21/07/2003 | 9,25 | 9,50 | 9,18 | 9,43 | +1,89% | 3,51% | 430.800 |
| 18/07/2003 | 9,24 | 9,33 | 9,12 | 9,25 | +1,09% | 2,27% | 865.600 |
| 17/07/2003 | 9,74 | 9,74 | 9,00 | 9,15 | -5,86% | 7,60% | 1.386.200 |
| 16/07/2003 | 9,85 | 10,15 | 9,70 | 9,72 | -2,85% | 4,52% | 385.000 |
| 15/07/2003 | 10,20 | 10,41 | 9,96 | 10,01 | -1,91% | 4,41% | 328.800 |
| 14/07/2003 | 10,53 | 10,67 | 10,01 | 10,20 | -0,49% | 6,27% | 908.800 |
| 11/07/2003 | 11,58 | 11,58 | 9,95 | 10,25 | -12,02% | 14,04% | 3.869.600 |
| 10/07/2003 | 11,47 | 11,77 | 11,18 | 11,65 | +0,13% | 5,14% | 688.600 |
| 09/07/2003 | 11,47 | 11,66 | 11,16 | 11,64 | +2,51% | 4,36% | 449.600 |
| 08/07/2003 | 11,25 | 11,55 | 11,21 | 11,35 | +0,71% | 3,07% | 525.600 |
| 07/07/2003 | 10,72 | 11,43 | 10,72 | 11,27 | +5,28% | 6,63% | 839.200 |
| 03/07/2003 | 10,50 | 10,71 | 10,50 | 10,71 | +1,47% | 2,00% | 269.000 |
| 02/07/2003 | 10,50 | 10,58 | 10,38 | 10,55 | +0,76% | 1,90% | 438.600 |
| 01/07/2003 | 10,77 | 10,91 | 10,42 | 10,47 | -3,23% | 4,55% | 789.800 |
| 30/06/2003 | 10,83 | 10,93 | 10,65 | 10,82 | +0,65% | 2,59% | 669.400 |
| 27/06/2003 | 10,66 | 10,98 | 10,66 | 10,75 | +0,19% | 3,00% | 447.400 |
| 26/06/2003 | 10,64 | 10,87 | 10,47 | 10,73 | +2,19% | 3,76% | 416.600 |
| 25/06/2003 | 10,47 | 10,72 | 10,42 | 10,50 | +0,43% | 2,82% | 282.400 |
| 24/06/2003 | 10,37 | 10,54 | 10,37 | 10,46 | +0,14% | 1,69% | 445.600 |
| 23/06/2003 | 10,70 | 10,70 | 10,40 | 10,44 | -2,02% | 2,80% | 303.200 |